SOPHARMA AD: Current report 122 buy back 12092013

opublikowano: 2013-09-12 09:56

Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Current_report_122_buy_back_12092013.doc  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 122 / 2013
Date of issue: 2013-09-12
Short name of the issuer
SOPHARMA AD
Subject
Current report 122 buy back 12092013
Official market - legal basis
Art. 56 ust. 1 pkt 1 Ustawy o ofercie - informacje poufne
Unofficial market - legal basis
Contents of the report:
SOPHARMA AD (the “Company") hereby informs that from 5 September 2013 up to and including 11 September 2013 the Company bought 2300 own shares representing 0.0017 % of the share capital of the Company, to the total value of 7 516.30 BGN on the Bulgarian Stock Exchange. The average price per share was 3.27 BGN.

The shares have been bought on the basis of decision No. 7 of the Annual General Meeting of Shareholders from 23 June 2010.

The total number of treasury shares after these transactions is 5 215 717, representing 3.95% of the share capital of the Company.
Annexes
File Description
Current report 122 buy back 12092013.docCurrent report 122 buy back 12092013.doc Current report 122 buy back 12092013

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2013-09-12 Ognian Donev Executive Director